New cochlear implants show promise for severe hearing loss

NCT ID NCT04610112

Completed Disease control Sponsor: Advanced Bionics AG Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested two types of cochlear implants in 30 adults with severe-to-profound hearing loss who had never used an implant before. The goal was to see if the devices are safe and help people understand speech better in quiet and noisy settings. Participants received the implant as part of routine care and were followed to measure their hearing improvements.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: cochlear implant (HiRes Ultra and HiRes Ultra 3D with HiFocus MS electrode)
What this could lead to: If successful, this could confirm that these implants are safe and help improve speech understanding for people with severe hearing loss.
What could go wrong: This is a small, completed study focused on safety and performance, not a cure. Results may not apply to all hearing loss types or guarantee long-term benefit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COCHLEAR HEARING LOSS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hearing loss disorder Hearing Loss, Sensorineural sensorineural hearing loss disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COCHLEAR HEARING LOSS

Contacts and locations

Locations

Heilig Geist Hospital Bensheim

Bensheim, Hesse, 64625, Germany
Klinik für HNO-Heilkunde. Kopf- imd Halschirurgie

Mannheim, 68167, Germany
Unfallkrankenhaus Berlin (UKB

Berlin, State of Berlin, 12683, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.